Fluidigm Stock Price - FLDM

0.02 (0.44%)
Best deals to access real time data!
CHART Trader
Monthly Subscription
for only
Canadian Level 1 + USA
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Fluidigm Corporation FLDM NASDAQ Common Stock
  Price Change Change Percent Stock Price Low Price High Price Open Price Close Price Last Traded
0.19 4.36% 4.55 4.32 4.7673 4.35 4.36 19:01:44
Bid Price Ask Price Spread Spread % News
4.57 4.58 0.01 0.22% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
8,863 1,240,391 $ 4.61 $ 5,722,323 2,822,697 1.17 - 14.295
Last Trade Time Type Quantity Stock Price Currency
19:01:41 formt 100 $ 4.57 USD

Fluidigm Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 321.71M 70.71M 69.96M $ 117.24M $ -56.51M -1.01 -5.69
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% 25.00 1.10%

more financials information »

Fluidigm News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical FLDM Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week4.884.974.274.501,382,453-0.33-6.76%
1 Month3.045.742.764.363,137,8481.5149.67%
3 Months2.805.741.173.621,694,4351.7562.5%
6 Months2.515.741.173.581,196,2122.0481.27%
1 Year13.1414.2951.174.881,033,181-8.59-65.37%
3 Years4.5314.901.176.30590,3100.020.44%
5 Years22.0026.111.177.22484,713-17.45-79.32%

Fluidigm Description

Fluidigm Corp manufactures life science tools focused on the analysis of single cells and industrial applications of genomics. These tools are based on microfluidics and mass cytometry technologies. It sells instruments and consumables, including integrated fluidic circuits, assays, and reagents. Slightly more than half of the firm's revenue comes from the sale of Consumables. Fluidigm primarily sells its products to academic institutions, clinical laboratories, and biopharmaceutical companies. The majority of revenue is generated in the United States followed by EMEA and Asia-Pacific.

Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.